Navigation Links
Medifast Receives Notice Regarding NYSE Listing
Date:12/26/2007

OWINGS MILLS, Md., Dec. 26 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) announced today that it has been notified by the New York Stock Exchange (the "NYSE") that it is not in compliance with the NYSE's continued listing standards. Medifast, Inc. is considered below criteria by the NYSE because over a consecutive 30-day trading period its total market capitalization was less than $75 million and the Company's most recently reported shareholders' equity was below $75 million. Under applicable NYSE procedures, the Company has 45 days from the receipt of the notice to submit a plan to the NYSE to demonstrate its ability to achieve compliance with the continued listing standards within 18 months. The Company plans to submit a plan that will demonstrate compliance with the listing standards within the required time frame.

About Medifast: (http://www.choosemedifast.com)

Medifast has been helping people lose weight and achieve better health for 25 years. Its meal replacement foods have been proven effective in multiple clinical studies, recommended by over 15,000 physicians and used by more than 1 million customers. Medifast offers its customers world-class customer service and nutrition support.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's o
'/>"/>

SOURCE Medifast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Medifast Announces Winners of Mother-Daughter Challenge
2. Medifast, Inc. Announces Support for Microsoft HealthVault
3. Medifast Announces Updated Full Year 2007 Guidance
4. Medifast Announces Third-Quarter 2007 Results
5. Medifast, Inc. Receives Approval to Sell Medifast Weight Control Centers Franchises in Seven Additional States
6. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
7. Medifast, Inc. Director of Research & Development Co-Authors Health Book
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Mass., Nov. 27 GSI Gro...plier of precision technology products and semicon...ting of the Company,s shareholders has been schedu...tion of the meeting will be announced in due cours...a requisition notice from Stephen Bershad, a holde...
(Date:11/27/2009)...ISCO, Nov. 27 The Gymbor...ir Lambert, CFO/COO, will present at the NASDAQ OM... May Fair Hotel in London, England, on Wednesday, ...en to a live broadcast of The Gymboree Corporation...o www.gymboree.com, click on "Our Company" at the ...
(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)... Voyant Health™ announced today that Sp...d its TraumaCad Enterprise orthopedic templating s.... , (PRWEB) November 27, ...Spectrum Health (Grand Rapids, Michigan) has licen... solution and its TraumaCad Extend workflow soluti...
(Date:11/26/2009)..., Nov. 27 With cold and flu season...good practices to control the spread of infections... not only to keep ourselves healthy, but to avoid ...inerty, RN, MS, CIC (certified in infection-contro...upational health at Hospital for Special Surgery (...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
... today announced that it has been recognized with ...Atlanta Metropolitan Partnership in Aging. The awa...ng a series of health education focused events for...erative Extension Service. , , "This allianc...
...orporated,(Nasdaq: ARAY ), a global leader in th...ovember 14, 2008, the Company received a notice fr...in compliance with the Nasdaq Marketplace Rule,431...r days following receipt of the notice, Accuray wi...
...ervice advertising,agency, recently received two p...;,Media (MM&M), a leading healthcare publicati...vity and effectiveness in healthcare marketing. M...m.com/cgi-bin/prnh/20081119/AQW573 ) , (Logo...
... treatment, experts say , , WEDNESDAY, Nov...,ve developed a new long-term method of monitoring... within the body. , Modifying a patient,s own immu... Medicine reports. However, efforts to track these...
...ard G. Rendell today revised his July 8 executive ... Health Care Cost Containment Council (PHC4). Unde...eration through June 30, 2009, or until the Genera...eneral Assembly. It was later reauthorized by legi...
...imprint of Kimani Press of Harlequin Enterprises, ...rch Hospital(R) in conjunction with its fall book ...s presented recently at a reception for the book s...rster attended to autograph copies of their books ...
Other Medicine News:Health News:Care Improvement Plus Recognized with Metropolitan Partnership in Aging Award 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 2Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 3Health News:Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q 4Health News:Mangos Wins Two Gold Awards 2Health News:Technique Tracks Cancer-Killing Cells 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 2Health News:Governor Rendell Revises Executive Order; Extends Operation of PA Health Care Cost Containment Council 3Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2
(Date:11/25/2009)...if., Nov. 25 AMPAC Fine Chemicals ...ation (Nasdaq: APFC ) announced today that it rec...ability Award at the Annual Statewide Environmenta...s and Technology Association (CMTA), the Industria... Industry Council of California (CICC) held in San...
(Date:11/25/2009)...Nov. 25 Abaxis, Inc. (Na...uring point-of-care blood analysis systems, announ...executive officer, will present at the 21st Annual..., December 2, 2009 at 2:00 p.m. ET. The conference...York City. ,, About Abaxis ,, Abaxis deve...
(Date:11/25/2009).... 25 Reportlinker.com announces th...s catalogue: ,, Pain Management - Global Tren...ain-Management---Global-Trends.html ,, Widespr...in management clinics, and the advent of new drugs...anagement market. Healthcare reforms and reimburse...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Open Letter to Congress on Long Term Care Insurance and Health Care Reform 58188 1Open Letter to Congress on Long Term Care Insurance and Health Care Reform 58188 2Leader in Elder Care Award to Posit Science CEO 58186 1Leader in Elder Care Award to Posit Science CEO 58186 2Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 1Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 2Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 3
...7 APA Meeting Also Showed No,Significant Impact on..., Pa., May 21, 2007 /PRNewswire-FirstCall/ --,Find...ning the,effect of desvenlafaxine succinate on anx...sociated with major depressive disorder,(MDD) -- a... the,effect of desvenlafaxine succinate on weight ...
...ting -, COLLEGEVILLE, Pa., May 21, 2007 /PRNewswir...ng safety and efficacy of,desvenlafaxine succinate...NRI) being studied as a potential treatment for ad...esented today at the,2007 American Psychiatric Ass...yeth Pharmaceuticals, a division of Wyeth . Result...
Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
... is produced in the adrenal cortex and, to a lesse...cursor in testosterone and estrogen synthesis, and...d at ~10% that of testosterone [1]. However, in ne...DHEA is an important androgen as circulating DHEA ...
...he first, easy-to-use, non-invasive diagnostic tec...ickly rule-in cardiac dysfunction including acute ...high-risk cardiac conditions. Designed to seamless...s enable clinicians caring for cardiac patients in...
...uced primarily by 5-monodeioination of thyroxine (...gland, T3 production occurs at a rate which is ~3-...e thyroid gland into the blood is ~5-8 micrograms/...n addition, approximately 22 mg/day of T3 is produ...
...n (GHBP) is the soluble, extra-cellular domain of ...l component of the growth hormone-insulin-like gro...it is either a cleavage product of the GH receptor...wth Hormone receptor cleavage /GHBP shedding is ef...
Medicine Products: